Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Sandlie

Showing results (31-40 of 48) with videos related to

Pageof 5
Sort By:
European Journal of Immunology|October 1, 1994
Human IgG isotype-specific amino acid residues affecting complement-mediated cell lysis and phagocytosisO H Brekke, T E Michaelsen, A Aase, et al.
Scandinavian Journal of Immunology|November 13, 2009
Structural difference in the complement activation site of human IgG1 and IgG3T E Michaelsen, I Sandlie, D B Bratlie, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 15, 1996
Effect of the IgM and IgA secretory tailpieces on polymerization and secretion of IgM and IgGV Sørensen, I B Rasmussen, L Norderhaug, et al.
Cancer Immunology, Immunotherapy : CII|September 29, 1999
Complement-mediated lysis of cultured osteosarcoma cell lines using chimeric mouse/human TP-1 IgG1 and IgG3 antibodiesT Olafsen, C K Munthe Lund, O S Bruland, et al.
Molecular Immunology|June 8, 2001
Lysine 322 in the human IgG3 C(H)2 domain is crucial for antibody dependent complement activationJ E Thommesen, T E Michaelsen, G Å Løset, et al.
Molecular Immunology|November 1, 1993
Human IgG3 can adopt the disulfide bond pattern characteristic for IgG1 without resembling it in complement mediated cell lysisO H Brekke, B Bremnes, R Sandin, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 27, 1994
One disulfide bond in front of the second heavy chain constant region is necessary and sufficient for effector functions of human IgG3 without a genetic hingeT E Michaelsen, O H Brekke, A Aase, et al.
International Reviews of Immunology|March 14, 2002
"Troy-bodies": recombinant antibodies that target T cell epitopes to antigen presenting cellsE Lund, I B Rasmussen, K H Western, et al.
European Journal of Immunology|October 1, 1991
Chimeric mouse human IgG3 antibodies with an IgG4-like hinge region induce complement-mediated lysis more efficiently than IgG3 with normal hingeL Norderhaug, O H Brekke, B Bremnes, et al.
European Journal of Immunology|February 13, 2001
Recombinant chimeric OKT3 scFv IgM antibodies mediate immune suppression while reducing T cell activation in vitroI Choi, C De Ines, T Kürschner, et al.
Pageof 5

Showing results (31-40 of 48) with videos related to

Sort By:
Pageof 5
European Journal of Immunology|October 1, 1994
Human IgG isotype-specific amino acid residues affecting complement-mediated cell lysis and phagocytosisO H Brekke, T E Michaelsen, A Aase, et al.
Scandinavian Journal of Immunology|November 13, 2009
Structural difference in the complement activation site of human IgG1 and IgG3T E Michaelsen, I Sandlie, D B Bratlie, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 15, 1996
Effect of the IgM and IgA secretory tailpieces on polymerization and secretion of IgM and IgGV Sørensen, I B Rasmussen, L Norderhaug, et al.
Cancer Immunology, Immunotherapy : CII|September 29, 1999
Complement-mediated lysis of cultured osteosarcoma cell lines using chimeric mouse/human TP-1 IgG1 and IgG3 antibodiesT Olafsen, C K Munthe Lund, O S Bruland, et al.
Molecular Immunology|June 8, 2001
Lysine 322 in the human IgG3 C(H)2 domain is crucial for antibody dependent complement activationJ E Thommesen, T E Michaelsen, G Å Løset, et al.
Molecular Immunology|November 1, 1993
Human IgG3 can adopt the disulfide bond pattern characteristic for IgG1 without resembling it in complement mediated cell lysisO H Brekke, B Bremnes, R Sandin, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 27, 1994
One disulfide bond in front of the second heavy chain constant region is necessary and sufficient for effector functions of human IgG3 without a genetic hingeT E Michaelsen, O H Brekke, A Aase, et al.
International Reviews of Immunology|March 14, 2002
"Troy-bodies": recombinant antibodies that target T cell epitopes to antigen presenting cellsE Lund, I B Rasmussen, K H Western, et al.
European Journal of Immunology|October 1, 1991
Chimeric mouse human IgG3 antibodies with an IgG4-like hinge region induce complement-mediated lysis more efficiently than IgG3 with normal hingeL Norderhaug, O H Brekke, B Bremnes, et al.
European Journal of Immunology|February 13, 2001
Recombinant chimeric OKT3 scFv IgM antibodies mediate immune suppression while reducing T cell activation in vitroI Choi, C De Ines, T Kürschner, et al.
Pageof 5